[普诺安（吡贝地尔）在帕金森病中的应用：一项多中心研究结果]

[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].

作者信息

Fedorova N V

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(11):21-4.

PMID:14681961

Abstract

The study of 99 patients has been conducted in 5 Russian centers. Pronoran ("Servier", France) combined with levodopa was used in dosage 50-150 mg daily during 6 months. The treatment was placebo-controlled. Significant differences (p < 0.001) between the study and control groups in expression of all main symptoms of the disease were found.

摘要

在俄罗斯的5个中心对99名患者进行了研究。使用普罗诺兰（法国施维雅公司生产）联合左旋多巴，每日剂量为50 - 150毫克，持续6个月。该治疗以安慰剂为对照。研究组和对照组在该疾病所有主要症状的表现上存在显著差异（p < 0.001）。